» Articles » PMID: 30456649

Berberine Ameliorates Lipopolysaccharide-induced Learning and Memory Deficit in the Rat: Insights into Underlying Molecular Mechanisms

Overview
Journal Metab Brain Dis
Publisher Springer
Specialties Endocrinology
Neurology
Date 2018 Nov 21
PMID 30456649
Citations 32
Authors
Affiliations
Soon will be listed here.
Abstract

Systemic lipopolysaccharide (LPS) triggers neuroinflammation with consequent development of behavioral and cognitive deficits. Neuroinflammation plays a crucial role in the pathogenesis of neurodegenerative disorders including Alzheimer's disease (AD). Berberine is an isoquinoline alkaloid in Berberis genus with antioxidant and anti-inflammatory property and protective effects in neurodegenerative disorders. In this research, beneficial effect of this alkaloid against LPS-induced cognitive decline was assessed in the adult male rats. LPS was intraperitoneally administered at a dose of 1 mg/kg to induce neuroinflammation and berberine was given via gavage at doses of 10 or 50 mg/kg, one h after LPS, for 7 days. Treatment of LPS group with berberine at a dose of 50 mg/kg (but not at a dose of 10 mg/kg) improved spatial recognition memory in Y maze, performance in novel object recognition task (NORT), and prevented learning and memory dysfunction in passive avoidance tasks. Furthermore, berberine lowered hippocampal activity of acetylcholinesterase (AChE), malondialdehyde (MDA), protein carbonyl, activity of caspase 3, and DNA fragmentation and improved antioxidant capacity through enhancing glutathione peroxidase (GPx), superoxide dismutase (SOD), catalase, and glutathione (GSH). Besides, berberine attenuated inflammation-related indices, as was evident by lower levels of nuclear factor-kappa B (NF-κB), toll-like receptor 4 (TLR4), tumor necrosis factor α (TNFα), and interleukin 6 (IL-6). Berberine also appropriately restored hippocampal 3-nitrotyrosine (3-NT), cyclooxygenase 2 (Cox 2), glial fibrillary acidic protein (GFAP), sirtuin 1, and mitogen-activated protein kinase (p38 MAPK) with no significant alteration of brain-derived neurotrophic factor (BDNF). In summary, berberine could partially ameliorate LPS-induced cognitive deficits via partial suppression of apoptotic cascade, neuroinflammation, oxido-nitrosative stress, AChE, MAPK, and restoration of sirtuin 1.

Citing Articles

The Effect of Disulfiram and N-Acetylcysteine, Potential Compensators for Sulfur Disorders, on Lipopolysaccharide-Induced Neuroinflammation Leading to Memory Impairment and the Metabolism of L-Cysteine Disturbance.

Iciek M, Bilska-Wilkosz A, Gorny M, Bednarski M, Zygmunt M, Miller A Molecules. 2025; 30(3).

PMID: 39942681 PMC: 11820383. DOI: 10.3390/molecules30030578.


Network pharmacology study on the mechanism of berberine in Alzheimer's disease model.

Zhang Y, Lv S, Huang P, Xiao L, Lin N, Huang E NPJ Sci Food. 2025; 9(1):16.

PMID: 39900946 PMC: 11790853. DOI: 10.1038/s41538-025-00378-y.


Protective effects of berberine against diabetes-associated cognitive decline in mice.

Gupta M, Rumman M, Singh B, Pandey S Acta Diabetol. 2024; .

PMID: 39514003 DOI: 10.1007/s00592-024-02411-0.


Neuroprotective Effects of Metformin and Berberine in Lipopolysaccharide-Induced Sickness-Like Behaviour in Mice.

Kodi T, Praveen S, Paka S, Sankhe R, Gopinathan A, Krishnadas N Adv Pharmacol Pharm Sci. 2024; 2024:8599268.

PMID: 39346967 PMC: 11438515. DOI: 10.1155/2024/8599268.


Hibiscetin attenuates lipopolysaccharide-evoked memory impairment by inhibiting BDNF/caspase-3/NF-κB pathway in rodents.

Gilani S, Bin Jumah M, Fatima F, Al-Abbasi F, Afzal M, Alzarea S PeerJ. 2024; 12:e16795.

PMID: 38313003 PMC: 10838095. DOI: 10.7717/peerj.16795.


References
1.
Leal G, Bramham C, Duarte C . BDNF and Hippocampal Synaptic Plasticity. Vitam Horm. 2017; 104:153-195. DOI: 10.1016/bs.vh.2016.10.004. View

2.
Ownby R . Neuroinflammation and cognitive aging. Curr Psychiatry Rep. 2010; 12(1):39-45. DOI: 10.1007/s11920-009-0082-1. View

3.
Kim M, Cho K, Shin M, Lee J, Cho H, Kim C . Berberine prevents nigrostriatal dopaminergic neuronal loss and suppresses hippocampal apoptosis in mice with Parkinson's disease. Int J Mol Med. 2014; 33(4):870-8. DOI: 10.3892/ijmm.2014.1656. View

4.
Pardon M . Lipopolysaccharide hyporesponsiveness: protective or damaging response to the brain?. Rom J Morphol Embryol. 2015; 56(3):903-13. View

5.
Zarezadeh M, Baluchnejadmojarad T, Kiasalari Z, Afshin-Majd S, Roghani M . Garlic active constituent s-allyl cysteine protects against lipopolysaccharide-induced cognitive deficits in the rat: Possible involved mechanisms. Eur J Pharmacol. 2016; 795:13-21. DOI: 10.1016/j.ejphar.2016.11.051. View